BRIEF published on 08/31/2026 at 07:05, 20 days 17 hours ago Advicenne withdraws the application for registration of ADV7103 in the United States FDA Pharmaceutical Registration Advicenna Sibnayal
PRESS RELEASE published on 08/31/2026 at 07:00, 20 days 17 hours ago Inside Information / Other news releases Advicenne voluntarily withdraws NDA for ADV7103 in the USA due to CMC-related work issues. Company hosting French webinar for shareholders. ADV7103 approved in EU, UK, KSA, UAE Pharmaceutical Webinar Advicenne ADV7103 NDA Withdrawal
BRIEF published on 07/16/2026 at 18:40, 2 months 4 days ago Advicenne's Revenue Surge in First Half of 2026 Revenue Growth Advicenne Sibnayal® Likozam® Pharmaceutical Sales
PRESS RELEASE published on 07/16/2026 at 18:35, 2 months 4 days ago Inside Information / Other news releases Advicenne reports significant revenue growth in first half of 2026 driven by Sibnayal® and Likozam® reimbursement in France, ending negative impact of early access rebates. Sales of Sibnayal® and Likozam® increased in volume Revenue Growth France Advicenne Sibnayal® Likozam®
BRIEF published on 07/01/2026 at 17:50, 2 months 19 days ago Unlimited renewal of the marketing authorization for Sibnayal® by Advicenne in the United Kingdom United Kingdom Advicenna Sibnayal Rare Kidney Diseases Marketing Authorization Renewal
BRIEF published on 06/22/2026 at 19:12, 2 months 28 days ago Advicenne Secures Financing to Q2 2027 with New Bond Issue Strategic Development Bond Financing FDA Registration Advicenne Rare Kidney Diseases
PRESS RELEASE published on 06/22/2026 at 19:07, 2 months 28 days ago Inside Information / Other news releases Advicenne secures €3.8 million bond financing, extending cash runway to Q2 2027, for FDA registration of ADV7103 in the USA Bond Financing FDA Registration Advicenne Cash Runway ADV7103
BRIEF published on 06/01/2026 at 07:50, 3 months 19 days ago Advicenne receives reimbursement for Likozam® and reduces its debt Advicenna Refund Likozam Debt Reduced Discounts Early Access
BRIEF published on 05/21/2026 at 21:07, 3 months 30 days ago Advicenne: Evolution of governance and challenges ahead Governance Pharmaceutical Restructuring Advicenna Sibnayal®
BRIEF published on 05/21/2026 at 21:07, 3 months 30 days ago Advicenne Announces Governance Changes Post-AGM Annual General Meeting Financial Restructuring Board Appointments Governance Changes Advicenne
Published on 09/19/2026 at 00:55, 1 day 23 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 2 days 2 hours ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 2 days 3 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days 9 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/20/2026 at 15:10, 9 hours 14 minutes ago MSITEK Participates in New York Fashion Week Retail Innovation Lab
Published on 09/20/2026 at 09:05, 15 hours 19 minutes ago Huawei Digital Power Showcases Multi-Scenario Solutions Featuring Grid Forming and AI at IDEE 2026
Published on 09/20/2026 at 06:30, 17 hours 54 minutes ago Huawei Grid-Interactive AIDC Solution: Shaping the New Paradigm of AI Infrastructure
Published on 09/20/2026 at 04:35, 19 hours 49 minutes ago How to Achieve Sustainable Power Without Changing Your Existing Backup System
Published on 09/19/2026 at 16:40, 1 day 7 hours ago 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Published on 09/18/2026 at 18:34, 2 days 5 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/17/2026 at 17:40, 3 days 6 hours ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
